Table 2.
Sociodemographic, anthropometric, and drug use characteristics in patients with metabolic syndrome, belonging to the control group (C) and supplemented group (S).
| Variables | Groups | |
|---|---|---|
| C (n = 25) | S (n = 25) | |
| Mean ± SE | Mean ± SE | |
| Age (years) | 49.17 ± 2.56 | 52.6 ± 2.24 |
|
| ||
| Age group∗ | ||
| Up to 59 years | 20 (80%) | 19 (76%) |
| 60 years and over | 5 (20%) | 6 (24%) |
|
| ||
| Gender∗ | ||
| Female | 18 (72%) | 17 (68%) |
| Male | 7 (28%) | 8 (32%) |
| BMI (kg/m2) | 33.72 ± 1.28 | 32.98 ± 0.71 |
|
| ||
| Adults∗ | ||
| Eutrophy | — | — |
| Overweight | 7 (33.3%) | 5 (21.7%) |
| Obesity | 14 (66.5%) | 16 (73.8%) |
|
| ||
| Elderly∗ | ||
| Eutrophy | — | — |
| Overweight | 2 (50%) | 2 (66.6%) |
| Obesity | 2 (50%) | 1 (33.3%) |
| Systolic blood pressure (mmHg) | 128 ± 6 | 131.6 ± 3 |
| Diastolic blood pressure (mmHg) | 82 ± 3 | 84.8 ± 2 |
|
| ||
| Drugs in use∗ | ||
| ACEI/ARBs | 20 (80%) | 21 (84%) |
| Statins | 13 (52%) | 12 (48%) |
| Oral hypoglyclers | 9 (36%) | 7 (28%) |
| Diuretics | 8 (32%) | 7 (28%) |
∗Outcome presented in the form of n (%). SE: standard error; ACEI: angiotensin-converting enzyme inhibitor; ARBs: angiotensin receptor blockers II.